199 related articles for article (PubMed ID: 24675206)
1. Characterization, prophylaxis, and treatment of infectious complications in craniomaxillofacial and upper extremity allotransplantation: a multicenter perspective.
Broyles JM; Alrakan M; Ensor CR; Khalifian S; Kotton CN; Avery RK; Brandacher G; Lee WPA; Gordon CR
Plast Reconstr Surg; 2014 Apr; 133(4):543e-551e. PubMed ID: 24675206
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus and other infectious issues related to face transplantation: specific considerations, lessons learned, and future recommendations.
Gordon CR; Avery RK; Abouhassan W; Siemionow M
Plast Reconstr Surg; 2011 Apr; 127(4):1515-1523. PubMed ID: 21460660
[TBL] [Abstract][Full Text] [Related]
3. Infections in composite tissue allograft recipients.
Hammond SP
Infect Dis Clin North Am; 2013 Jun; 27(2):379-93. PubMed ID: 23714346
[TBL] [Abstract][Full Text] [Related]
4. Vascularized composite allotransplantation: an update on medical and surgical progress and remaining challenges.
Murphy BD; Zuker RM; Borschel GH
J Plast Reconstr Aesthet Surg; 2013 Nov; 66(11):1449-55. PubMed ID: 23867239
[TBL] [Abstract][Full Text] [Related]
5. What is the true significance of donor-related cytomegalovirus transmission in the setting of facial composite tissue allotransplantation?
Gordon CR; Abouhassan W; Avery RK
Transplant Proc; 2011 Nov; 43(9):3516-20. PubMed ID: 22099832
[TBL] [Abstract][Full Text] [Related]
6. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
[TBL] [Abstract][Full Text] [Related]
7. Donor and Recipient Matching in Facial Vascularized Composite Allotransplantation: A Closer Look at the Donor Pool.
Kauke M; Haug V; Obed D; Diehm Y; Tchiloemba B; Safi AF; Pomahac B
Plast Reconstr Surg; 2021 Jul; 148(1):194-202. PubMed ID: 34181616
[TBL] [Abstract][Full Text] [Related]
8. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
Schowengerdt KO; Naftel DC; Seib PM; Pearce FB; Addonizio LJ; Kirklin JK; Morrow WR
J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the rat hind limb transplant as an experimental model of vascularized composite allotransplantation: Approaches and advantages.
Fleissig YY; Beare JE; LeBlanc AJ; Kaufman CL
SAGE Open Med; 2020; 8():2050312120968721. PubMed ID: 33194200
[TBL] [Abstract][Full Text] [Related]
10. Donor-recipient human leukocyte antigen matching practices in vascularized composite tissue allotransplantation: a survey of major transplantation centers.
Ashvetiya T; Mundinger GS; Kukuruga D; Bojovic B; Christy MR; Dorafshar AH; Rodriguez ED
Plast Reconstr Surg; 2014 Jul; 134(1):121-129. PubMed ID: 25028821
[TBL] [Abstract][Full Text] [Related]
11. Influenza and other respiratory virus infections in solid organ transplant recipients.
Manuel O; López-Medrano F; Keiser L; Welte T; Carratalà J; Cordero E; Hirsch HH;
Clin Microbiol Infect; 2014 Sep; 20 Suppl 7(Suppl 7):102-8. PubMed ID: 26451405
[TBL] [Abstract][Full Text] [Related]
12. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
[TBL] [Abstract][Full Text] [Related]
13. [Infections in solid organ transplant recipients].
Cuellar-Rodríguez J; Sierra-Madero JG
Rev Invest Clin; 2005; 57(2):368-80. PubMed ID: 16524080
[TBL] [Abstract][Full Text] [Related]
14. Facial transplantation: worth the risks? A look at evolution of indications over the last decade.
Wo L; Bueno E; Pomahac B
Curr Opin Organ Transplant; 2015 Dec; 20(6):615-20. PubMed ID: 26536422
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and risk factors for late infection in solid organ transplant recipients.
Cervera C; Fernández-Ruiz M; Valledor A; Linares L; Antón A; Ángeles Marcos M; Sanclemente G; Hoyo I; Cofán F; Ricart MJ; Pérez-Villa F; Navasa M; Pumarola T; Moreno A
Transpl Infect Dis; 2011 Dec; 13(6):598-607. PubMed ID: 21535336
[TBL] [Abstract][Full Text] [Related]
16. Pediatric vascularized composite allotransplantation.
Doumit G; Gharb BB; Rampazzo A; Papay F; Siemionow MZ; Zins JE
Ann Plast Surg; 2014 Oct; 73(4):445-50. PubMed ID: 25072311
[TBL] [Abstract][Full Text] [Related]
17. Update on infections in composite tissue allotransplantation.
Avery RK
Curr Opin Organ Transplant; 2013 Dec; 18(6):659-64. PubMed ID: 24220048
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Multifunctional Outcome and Risks of Face Vascularized Composite Allotransplantation.
Roche NA; Blondeel PN; Vermeersch HF; Peeters PC; Lemmens GM; De Cubber J; De Letter M; Van Lierde K
J Craniofac Surg; 2015 Oct; 26(7):2038-46. PubMed ID: 26468783
[TBL] [Abstract][Full Text] [Related]
19. Acceptance of Vascularized Composite Allotransplantation (Face and Hand Transplant) in Singapore.
Hui CLY; Chen PPY; Tan BK; Ooi ASH
Ann Plast Surg; 2018 Nov; 81(5):615-618. PubMed ID: 30247196
[TBL] [Abstract][Full Text] [Related]
20. Experimental models of composite tissue allograft transplants.
Siemionow M; Kulahci Y
Semin Plast Surg; 2007 Nov; 21(4):205-12. PubMed ID: 20567673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
